Pneumococcal disease rates drop with PCV-13 vaccine

11/4/2013 | Family Practice News

Following the introduction of the 13-valent pneumococcal conjugate vaccine in 2010, cases of PCV13-type invasive pneumococcal disease in New York City dropped among children younger than 5 years old, according to a study presented at the IDWeek meeting. Overall, the incidence of PCV13-type pneumococcal disease declined 82% from 2007 to 2012, mostly among children younger than 12 months of age. Another study presented at the same meeting found that PCV13 serotype disease was more prevalent among unvaccinated children in Ontario in the second year following the implementation of the vaccine.

View Full Article in:

Family Practice News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA